8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Mar 2, 2026·SEC
Material company update
Feb 17, 2026·SEC
Glaukos Corporation(GKOS)Earnings, Financials & Key Ratios
GKOS•NYSE
$135.27
$7.92B mkt cap·Price updated May 6, 2026
AboutGlaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.Show more
- Revenue$507M+32.3%
- EBITDA-$44M+46.2%
- Net Income-$188M-28.2%
- EPS (Diluted)-3.28-18.4%
- Gross Margin77.49%+2.7%
- EBITDA Margin-8.75%+59.3%
- Operating Margin-17.09%+46.4%
- Net Margin-36.99%+3.1%
- ROE-26.38%-10.7%
- ROIC-9.24%+26.8%
- Debt/Equity0.21+54.2%
- Interest Coverage-18.71-38.6%
GKOS Key Insights
Glaukos Corporation (GKOS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 86 (top 14%)
- ✓Strong 5Y sales CAGR of 17.7%
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Expensive at 11.8x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GKOS Price & Volume
Glaukos Corporation (GKOS) stock price & volume — 10-year historical chart
Loading chart...
GKOS Growth Metrics
Glaukos Corporation (GKOS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years21.61%
5 Years17.67%
3 Years21.51%
TTM36.3%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-53.08%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-38.4%
Return on Capital
10 Years-8.03%
5 Years-9.82%
3 Years-12.63%
Last Year-10.25%
GKOS Recent Earnings
Glaukos Corporation (GKOS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 29, 2026EPS
$0.18
Est $0.30
+40.0%
Revenue
$151M
Est $137M
+9.9%
Q1 2026
Feb 17, 2026EPS
$0.28
Est $0.22
-27.3%
Revenue
$143M
Est $136M
+4.9%
Q4 2025
Oct 29, 2025EPS
$0.16
Est $0.27
+40.7%
Revenue
$134M
Est $129M
+3.2%
Q3 2025
Jul 30, 2025EPS
$0.24
Est $0.26
+7.7%
Revenue
$124M
Est $122M
+1.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.18vs $0.30+40.0% | $151Mvs $137M+9.9% |
| Q1 2026 | Feb 17, 2026 | $0.28vs $0.22-27.3% | $143Mvs $136M+4.9% |
| Q4 2025 | Oct 29, 2025 | $0.16vs $0.27+40.7% | $134Mvs $129M+3.2% |
| Q3 2025 | Jul 30, 2025 | $0.24vs $0.26+7.7% | $124Mvs $122M+1.4% |
Based on last 12 quarters of dataView full earnings history →
GKOS Peer Comparison
Glaukos Corporation (GKOS) competitors in Vision, dental, and ENT devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ATRC | 1.42B | 28.01 | -116.71 | 14.88% | -0.83% | -0.95% | 0.18 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 TNDM | 1.24B | 18.03 | -5.93 | 7.93% | -20.17% | -141.98% | 2.86 | |
 INSP | 1.32B | 45.70 | 9.35 | 13.6% | 14.33% | 17.98% | 0.04 | |
 EW | 47.97B | 83.20 | 45.46 | 11.55% | 17.64% | 10.35% | 0.07 | |
 ALGN | 12.46B | 173.94 | 30.79 | 0.9% | 10.5% | 10.7% | 0.03 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 10.37% | 0.52 | |
 IRTC | 3.87B | 117.70 | -84.68 | 26.24% | -3.53% | -20.6% | 4.79 |
Compare GKOS vs Peers
Glaukos Corporation (GKOS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GKOS Income Statement
Glaukos Corporation (GKOS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 159.25M | 181.28M | 236.98M | 224.96M | 294.01M | 282.86M | 314.71M | 383.48M | 507.44M | 551.35M |
| Revenue Growth % | 39.21% | 13.83% | 30.73% | -5.07% | 30.7% | -3.79% | 11.26% | 21.85% | 32.33% | 36.3% |
| Cost of Goods Sold | 21.05M | 25.07M | 38.59M | 91.72M | 66.63M | 68.98M | 75.58M | 94.03M | 114.23M | 120.84M |
| COGS % of Revenue | 13.22% | 13.83% | 16.28% | 40.77% | 22.66% | 24.39% | 24.01% | 24.52% | 22.51% | - |
| Gross Profit | 138.2M▲ 0% | 156.2M▲ 13.0% | 198.4M▲ 27.0% | 133.24M▼ 32.8% | 227.38M▲ 70.7% | 213.88M▼ 5.9% | 239.14M▲ 11.8% | 289.45M▲ 21.0% | 393.22M▲ 35.8% | 430.51M▲ 0% |
| Gross Margin % | 86.78% | 86.17% | 83.72% | 59.23% | 77.34% | 75.61% | 75.99% | 75.48% | 77.49% | 78.08% |
| Gross Profit Growth % | 40.71% | 13.02% | 27.01% | -32.84% | 70.66% | -5.94% | 11.81% | 21.04% | 35.85% | - |
| Operating Expenses | 140.49M | 169.21M | 248.69M | 256.79M | 260.26M | 296.2M | 367.84M | 411.82M | 479.95M | 516.42M |
| OpEx % of Revenue | 88.21% | 93.34% | 104.94% | 114.15% | 88.52% | 104.71% | 116.88% | 107.39% | 94.58% | - |
| Selling, General & Admin | 96.26M | 119.53M | 176.63M | 171.4M | 179.26M | 192.93M | 224.07M | 262.85M | 329.33M | 354.02M |
| SG&A % of Revenue | 60.44% | 65.94% | 74.53% | 76.19% | 60.97% | 68.2% | 71.2% | 68.54% | 64.9% | - |
| Research & Development | 38.91M | 49.68M | 68.31M | 85.39M | 101M | 123.27M | 138.77M | 136.43M | 150.61M | 162.41M |
| R&D % of Revenue | 24.43% | 27.4% | 28.82% | 37.96% | 34.35% | 43.58% | 44.09% | 35.58% | 29.68% | - |
| Other Operating Expenses | 5.32M | 0 | 3.75M | 0 | -20M | -20M | 5M | 12.55M | 0 | 0 |
| Operating Income | -2.28M▲ 0% | -13M▼ 470.0% | -50.29M▼ 286.8% | -123.55M▼ 145.7% | -32.87M▲ 73.4% | -82.31M▼ 150.4% | -128.7M▼ 56.4% | -122.37M▲ 4.9% | -86.73M▲ 29.1% | -85.91M▲ 0% |
| Operating Margin % | -1.43% | -7.17% | -21.22% | -54.92% | -11.18% | -29.1% | -40.89% | -31.91% | -17.09% | -15.58% |
| Operating Income Growth % | -153.78% | -470.01% | -286.8% | -145.67% | 73.39% | -150.4% | -56.35% | 4.92% | 29.12% | - |
| EBITDA | 3.2M | -6.74M | -40.43M | -88.94M | 1.55M | -46.37M | -90.72M | -82.44M | -44.39M | -39.99M |
| EBITDA Margin % | 2.01% | -3.72% | -17.06% | -39.54% | 0.53% | -16.39% | -28.83% | -21.5% | -8.75% | -7.25% |
| EBITDA Growth % | -64.29% | -310.5% | -500.01% | -119.99% | 101.74% | -3093.35% | -95.66% | 9.12% | 46.16% | 38.23% |
| D&A (Non-Cash Add-back) | 5.48M | 6.26M | 9.86M | 34.61M | 34.42M | 35.95M | 37.98M | 39.92M | 42.34M | 45.92M |
| EBIT | 1K | -12.37M | -47.47M | -118.2M | -35.9M | -84.71M | -120.09M | -135.56M | -86.73M | -85.91M |
| Net Interest Income | 1.38M | 2.25M | 604K | -11.74M | -12.08M | -11.35M | -4.47M | 1.06M | 6.08M | 5.47M |
| Interest Income | 1.38M | 2.25M | 3.17M | 2.38M | 1.29M | 2.38M | 9.16M | 11.11M | 10.71M | 10.07M |
| Interest Expense | 0 | 0 | 2.56M | 14.12M | 13.37M | 13.72M | 13.63M | 10.04M | 4.63M | 4.6M |
| Other Income/Expense | 2.28M | 634K | 256K | -8.76M | -16.39M | -16.12M | -5.03M | -23.23M | -106.31M | -108.61M |
| Pretax Income | 1K▲ 0% | -12.37M▼ 1236900.0% | -50.04M▼ 304.6% | -132.31M▼ 164.4% | -49.27M▲ 62.8% | -98.43M▼ 99.8% | -133.73M▼ 35.9% | -145.6M▼ 8.9% | -193.04M▼ 32.6% | -194.52M▲ 0% |
| Pretax Margin % | 0% | -6.82% | -21.11% | -58.82% | -16.76% | -34.8% | -42.49% | -37.97% | -38.04% | -35.28% |
| Income Tax | 93K | 583K | -65.46M | -11.97M | 326K | 766K | 934K | 771K | -5.35M | -5.19M |
| Effective Tax Rate % | 9300% | -4.71% | 130.83% | 9.04% | -0.66% | -0.78% | -0.7% | -0.53% | 2.77% | 2.67% |
| Net Income | -92K▲ 0% | -12.95M▼ 13977.2% | 15.42M▲ 219.1% | -120.35M▼ 880.3% | -49.59M▲ 58.8% | -99.19M▼ 100.0% | -134.66M▼ 35.8% | -146.37M▼ 8.7% | -187.69M▼ 28.2% | -189.33M▲ 0% |
| Net Margin % | -0.06% | -7.14% | 6.51% | -53.5% | -16.87% | -35.07% | -42.79% | -38.17% | -36.99% | -34.34% |
| Net Income Growth % | -102.03% | -13977.17% | 219.1% | -880.26% | 58.79% | -100.02% | -35.75% | -8.7% | -28.23% | -53.08% |
| Net Income (Continuing) | -92K | -12.95M | 15.42M | -120.35M | -49.59M | -99.19M | -134.66M | -146.37M | -187.69M | -189.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.00▲ 0% | -0.37▼ 13603.7% | 0.37▲ 200.0% | -2.70▼ 829.7% | -1.07▲ 60.4% | -2.09▼ 95.3% | -2.78▼ 33.0% | -2.77▲ 0.4% | -3.28▼ 18.4% | -3.26▲ 0% |
| EPS Growth % | -102.25% | - | 200% | -829.73% | 60.37% | -95.33% | -33.01% | 0.36% | -18.41% | -38.4% |
| EPS (Basic) | -0.00 | -0.37 | 0.41 | -2.70 | -1.07 | -2.09 | -2.78 | -2.77 | -3.28 | - |
| Diluted Shares Outstanding | 34.38M | 35.32M | 41.15M | 44.5M | 46.42M | 47.44M | 48.43M | 52.76M | 57.19M | 58.02M |
| Basic Shares Outstanding | 34.38M | 35M | 37.35M | 44.5M | 46.42M | 47.44M | 48.43M | 52.76M | 57.19M | 58.02M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
GKOS Balance Sheet
Glaukos Corporation (GKOS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 149.46M | 176.57M | 262.88M | 469.44M | 486.13M | 443.86M | 395.46M | 449.79M | 474.98M | 485.75M |
| Cash & Short-Term Investments | 119.01M | 140.49M | 173.98M | 404.37M | 414.05M | 352.69M | 295.43M | 318.92M | 278.76M | 276.69M |
| Cash Only | 24.51M | 29.82M | 62.43M | 96.6M | 100.71M | 119.53M | 93.47M | 169.63M | 90.81M | 104.25M |
| Short-Term Investments | 94.51M | 110.67M | 111.55M | 307.77M | 313.34M | 233.17M | 201.96M | 149.29M | 187.95M | 172.44M |
| Accounts Receivable | 16.66M | 18.67M | 38.42M | 36.06M | 33.44M | 36.07M | 39.85M | 60.74M | 108.61M | 119.69M |
| Days Sales Outstanding | 38.17 | 37.6 | 59.17 | 58.51 | 41.51 | 46.55 | 46.22 | 57.82 | 78.12 | 67.85 |
| Inventory | 11.22M | 13.28M | 42.58M | 15.81M | 23.01M | 37.84M | 41.99M | 57.68M | 63.56M | 62.38M |
| Days Inventory Outstanding | 194.59 | 193.34 | 402.74 | 62.91 | 126.06 | 200.23 | 202.78 | 223.9 | 203.11 | 192.13 |
| Other Current Assets | 2.57M | 4.12M | 0 | 13.21M | 15.63M | 17.25M | 18.19M | 12.46M | 24.05M | 26.99M |
| Total Non-Current Assets | 16.38M | 30.4M | 555.52M | 536.06M | 642.7M | 630.31M | 544.95M | 524.96M | 418.5M | 407.57M |
| Property, Plant & Equipment | 11.79M | 19.15M | 91.81M | 95.46M | 146.13M | 166.83M | 174.54M | 169.94M | 184.18M | 182.26M |
| Fixed Asset Turnover | 13.50x | 9.46x | 2.58x | 2.36x | 2.01x | 1.70x | 1.80x | 2.26x | 2.76x | 3.01x |
| Goodwill | 0 | 0 | 66.13M | 66.13M | 66.13M | 66.13M | 66.13M | 66.13M | 66.71M | 66.71M |
| Intangible Assets | 3.15M | 0 | 382.61M | 357.69M | 332.78M | 307.87M | 282.96M | 263.44M | 141.92M | 133.03M |
| Long-Term Investments | 0 | 8.78M | 0 | 9.57M | 9.42M | 7.08M | 0 | 0 | 3.83M | 11.5M |
| Other Non-Current Assets | 1.2M | 11.04M | 14.97M | 7.21M | 9.11M | 10.61M | 21.32M | 25.45M | 21.86M | 100.33M |
| Total Assets | 165.84M▲ 0% | 206.97M▲ 24.8% | 818.4M▲ 295.4% | 1.01B▲ 22.9% | 1.13B▲ 12.3% | 1.07B▼ 4.8% | 940.41M▼ 12.5% | 974.76M▲ 3.7% | 893.49M▼ 8.3% | 893.33M▲ 0% |
| Asset Turnover | 0.96x | 0.88x | 0.29x | 0.22x | 0.26x | 0.26x | 0.33x | 0.39x | 0.57x | 0.58x |
| Asset Growth % | 23.42% | 24.8% | 295.42% | 22.86% | 12.26% | -4.84% | -12.45% | 3.65% | -8.34% | -0.7% |
| Total Current Liabilities | 26.79M | 30.36M | 57.7M | 49.7M | 63.36M | 72.36M | 74.01M | 75.13M | 101.28M | 89.42M |
| Accounts Payable | 6.24M | 6.29M | 5.78M | 4.37M | 7.33M | 14.4M | 13.44M | 13.03M | 24.62M | 19.15M |
| Days Payables Outstanding | 108.27 | 91.5 | 54.68 | 17.39 | 40.17 | 76.21 | 64.91 | 50.57 | 78.68 | 58.41 |
| Short-Term Debt | 0 | 0 | 0 | 1.19M | 1.01M | 430K | 0 | 2.47M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 95K | 115K | 13.53M | 29.6M | 33.81M | 35.83M | 20.59M | 0 | 76.65M | 70.26M |
| Current Ratio | 5.58x | 5.81x | 4.56x | 9.45x | 7.67x | 6.13x | 5.34x | 5.99x | 4.69x | 4.69x |
| Quick Ratio | 5.16x | 5.38x | 3.82x | 9.13x | 7.31x | 5.61x | 4.78x | 5.22x | 4.06x | 4.06x |
| Cash Conversion Cycle | 124.49 | 139.43 | 407.23 | 104.02 | 127.4 | 170.57 | 184.08 | 231.15 | 202.55 | 201.58 |
| Total Non-Current Liabilities | 846K | 2.75M | 87.43M | 288.35M | 478.32M | 471.8M | 404.63M | 132.7M | 136.06M | 132.98M |
| Long-Term Debt | 0 | 0 | 0 | 189.42M | 280.03M | 281.4M | 282.77M | 0 | 35.77M | 103.06M |
| Capital Lease Obligations | 0 | 0 | 72.63M | 81.39M | 102.35M | 101.08M | 100.97M | 103.4M | 103.88M | 313.21M |
| Deferred Tax Liabilities | 0 | 0 | 9.63M | 10.51M | 86.45M | 79.05M | 7.14M | 6.93M | 441K | 14.71M |
| Other Non-Current Liabilities | 846K | 2.75M | 5.17M | 7.03M | 9.49M | 10.28M | 13.75M | 22.37M | -4.03M | 87.32M |
| Total Liabilities | 27.63M | 33.11M | 145.13M | 338.05M | 541.68M | 544.16M | 478.65M | 207.82M | 237.33M | 222.4M |
| Total Debt | 0 | 0 | 72.63M | 272M | 383.38M | 382.91M | 383.74M | 105.87M | 139.64M | 103.06M |
| Net Debt | -24.51M | -29.82M | 10.2M | 175.4M | 282.68M | 263.38M | 290.27M | -63.75M | 48.83M | -1.19M |
| Debt / Equity | - | - | 0.11x | 0.41x | 0.65x | 0.72x | 0.83x | 0.14x | 0.21x | 0.21x |
| Debt / EBITDA | - | - | - | - | 247.50x | - | - | - | - | -2.58x |
| Net Debt / EBITDA | -7.66x | - | - | - | 182.49x | - | - | - | - | 0.03x |
| Interest Coverage | - | - | -18.51x | -8.37x | -2.68x | -6.17x | -8.81x | -13.50x | -18.71x | -18.69x |
| Total Equity | 138.2M▲ 0% | 173.86M▲ 25.8% | 673.27M▲ 287.2% | 667.45M▼ 0.9% | 587.15M▼ 12.0% | 530M▼ 9.7% | 461.77M▼ 12.9% | 766.93M▲ 66.1% | 656.15M▼ 14.4% | 670.93M▲ 0% |
| Equity Growth % | 17.85% | 25.8% | 287.25% | -0.86% | -12.03% | -9.73% | -12.88% | 66.09% | -14.44% | 3.52% |
| Book Value per Share | 4.02 | 4.92 | 16.36 | 15.00 | 12.65 | 11.17 | 9.53 | 14.54 | 11.47 | 11.56 |
| Total Shareholders' Equity | 138.2M | 173.86M | 673.27M | 667.45M | 587.15M | 530M | 461.77M | 766.93M | 656.15M | 670.93M |
| Common Stock | 35K | 36K | 44K | 45K | 47K | 48K | 49K | 56K | 58K | 58K |
| Retained Earnings | -192.18M | -205.13M | -189.71M | -310.06M | -365.21M | -464.41M | -599.07M | -745.44M | -933.13M | -952.91M |
| Treasury Stock | -132K | -132K | -132K | -132K | -132K | -132K | -132K | -132K | -132K | 0 |
| Accumulated OCI | -591K | 738K | 1.33M | 1M | 15K | -2.98M | 1.17M | 2.62M | 3.3M | 2.64M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GKOS Cash Flow Statement
Glaukos Corporation (GKOS) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 25.51M | 18.86M | -369K | -22.99M | 24.71M | -33.08M | -57.76M | -61.32M | -46.34M | -46.34M |
| Operating CF Margin % | 16.02% | 10.41% | -0.16% | -10.22% | 8.4% | -11.7% | -18.35% | -15.99% | -9.13% | - |
| Operating CF Growth % | 107.23% | -26.05% | -101.96% | -6129.81% | 207.48% | -233.9% | -74.59% | -6.16% | 24.43% | 1414.81% |
| Net Income | -92K | -12.95M | 15.42M | -120.35M | -49.59M | -99.19M | -134.66M | -146.37M | -133.66M | -189.33M |
| Depreciation & Amortization | 5.48M | 6.26M | 9.86M | 34.61M | 34.42M | 35.95M | 37.98M | 39.92M | 38.09M | 40.59M |
| Stock-Based Compensation | 17.59M | 25.7M | 0 | 46.48M | 30.15M | 38.56M | 43.53M | 50.21M | 63.22M | 69.38M |
| Deferred Taxes | -925K | 1.51M | -66.31M | -12.18M | -1.03M | -54K | -120K | -216K | -6.49M | -6.48M |
| Other Non-Cash Items | 722K | 1.92M | 45.12M | 31.67M | 7.19M | 5.11M | 5.65M | 34.62M | 24.04M | 53.86M |
| Working Capital Changes | 2.73M | -3.58M | -4.47M | -3.22M | 3.58M | -13.45M | -10.13M | -39.47M | -31.55M | 23.19M |
| Change in Receivables | -2.18M | -2.25M | -6.63M | 2.24M | 1.7M | -3.14M | -3.84M | -21.97M | -53.02M | -53.16M |
| Change in Inventory | -4.16M | -2.3M | 4.08M | 1.96M | -7.7M | -15.47M | -4.83M | -18.79M | 2.65M | 5.14M |
| Change in Payables | 9.23M | 771K | 779K | -2.68M | 12.45M | 7.21M | 1.3M | 21K | 18.82M | 15.36M |
| Cash from Investing | -11.73M | -26.4M | 43.43M | -205.06M | -58.23M | 44.78M | 14.1M | 47.83M | -77.61M | -30.16M |
| Capital Expenditures | -6.31M | -10.31M | -4.72M | -6.93M | -47.78M | -30.27M | -20.25M | -6.3M | -7.67M | -9.69M |
| CapEx % of Revenue | 3.96% | 5.69% | 1.99% | 3.08% | 16.25% | 10.7% | 6.43% | 1.64% | 1.51% | - |
| Acquisitions | 11.7K | 1.24M | 49.65M | 0 | 3K | 151K | 0 | 38K | -12.44M | -12.44M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -11.7K | -1.24M | -1.61M | -1.82M | -2.08M | -1.01M | -3.17M | -3.15M | -22.16M | -21.77M |
| Cash from Financing | 4.67M | 21.58M | -9.64M | 262.54M | 39.26M | 6.25M | 15.04M | 91.54M | 11.89M | 25.7M |
| Debt Issued (Net) | 0 | 0 | -22.5M | 242.21M | -659K | -527K | -711K | 51.34M | 0 | 248K |
| Equity Issued (Net) | 0 | 0 | 18.45M | 24.22M | 30.94M | 9.21M | 19.03M | 46.76M | 0 | -7.04M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -587K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 4.67M | 21.58M | -5.6M | -3.89M | 8.98M | -2.43M | -3.27M | -6.56M | 11.89M | 32.5M |
| Net Change in Cash | 18.01M▲ 0% | 14.09M▼ 21.8% | 32.61M▲ 131.5% | 34.17M▲ 4.8% | 4.11M▼ 88.0% | 18.82M▲ 357.6% | -26.06M▼ 238.5% | 76.16M▲ 392.3% | -111.26M▼ 246.1% | -10.9M▲ 0% |
| Free Cash Flow | 19.2M▲ 0% | 8.55M▼ 55.5% | -5.09M▼ 159.6% | -29.92M▼ 487.5% | -23.08M▲ 22.9% | -63.35M▼ 174.5% | -78.01M▼ 23.1% | -67.62M▲ 13.3% | -54.01M▲ 20.1% | -18.48M▲ 0% |
| FCF Margin % | 12.05% | 4.72% | -2.15% | -13.3% | -7.85% | -22.4% | -24.79% | -17.63% | -10.64% | -3.35% |
| FCF Growth % | 218.31% | -55.47% | -159.57% | -487.53% | 22.88% | -174.51% | -23.14% | 13.32% | 20.13% | 65.29% |
| FCF per Share | 0.56 | 0.24 | -0.12 | -0.67 | -0.50 | -1.34 | -1.61 | -1.28 | -0.94 | -0.94 |
| FCF Conversion (FCF/Net Income) | -277.26x | -1.46x | -0.02x | 0.19x | -0.50x | 0.33x | 0.43x | 0.42x | 0.25x | 0.10x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 12K | 401K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GKOS Key Ratios
Glaukos Corporation (GKOS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -0.07% | -8.3% | 3.64% | -17.95% | -7.91% | -17.76% | -27.16% | -23.83% | -26.38% | -26.46% |
| Return on Invested Capital (ROIC) | -1.52% | -7.57% | -9.12% | -12.14% | -2.88% | -7.42% | -12.49% | -12.61% | -9.24% | -9.24% |
| Gross Margin | 86.78% | 86.17% | 83.72% | 59.23% | 77.34% | 75.61% | 75.99% | 75.48% | 77.49% | 78.08% |
| Net Margin | -0.06% | -7.14% | 6.51% | -53.5% | -16.87% | -35.07% | -42.79% | -38.17% | -36.99% | -34.34% |
| Debt / Equity | - | - | 0.11x | 0.41x | 0.65x | 0.72x | 0.83x | 0.14x | 0.21x | 0.21x |
| Interest Coverage | - | - | -18.51x | -8.37x | -2.68x | -6.17x | -8.81x | -13.50x | -18.71x | -18.69x |
| FCF Conversion | -277.26x | -1.46x | -0.02x | 0.19x | -0.50x | 0.33x | 0.43x | 0.42x | 0.25x | 0.10x |
| Revenue Growth | 39.21% | 13.83% | 30.73% | -5.07% | 30.7% | -3.79% | 11.26% | 21.85% | 32.33% | 36.3% |
GKOS SEC Filings & Documents
Glaukos Corporation (GKOS) SEC filings — annual & quarterly reports (10-K, 10-Q)
GKOS Frequently Asked Questions
Glaukos Corporation (GKOS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Glaukos Corporation (GKOS) reported $551.3M in revenue for fiscal year 2025. This represents a 22599% increase from $2.4M in 2012.
Glaukos Corporation (GKOS) grew revenue by 32.3% over the past year. This is strong growth.
Glaukos Corporation (GKOS) reported a net loss of $189.3M for fiscal year 2025.
Dividend & Returns
Glaukos Corporation (GKOS) has a return on equity (ROE) of -26.4%. Negative ROE indicates the company is unprofitable.
Glaukos Corporation (GKOS) had negative free cash flow of $18.5M in fiscal year 2025, likely due to heavy capital investments.
Explore More GKOS
Glaukos Corporation (GKOS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates